Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suyash Deodhar

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Therapeutic Delivery|November 17, 2018
Long circulating liposomes: challenges and opportunitiesSuyash Deodhar, Alekha K Dash
Biotech (Basel (Switzerland))|July 13, 2022
Non-Viral Vectors for Delivery of Nucleic Acid Therapies for CancerShrey Kanvinde, Tanmay Kulkarni, Suyash Deodhar, et al.
Biotech (Basel (Switzerland))|May 23, 2023
Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary FibrosisShrey Kanvinde, Suyash Deodhar, Tanmay A Kulkarni, et al.
Mabs|June 8, 2026
Subcutaneous drug delivery of high concentration antibody products - part 2: formulation, device options, and clinical bridging strategies for patient-centric commercial presentationsIndrajit Ghosh, Suyash Deodhar, Hiten Gutka, et al.
Journal of Pharmaceutical Sciences|July 24, 2025
Development roadmap for subcutaneous delivery of high dose biologics - high concentration formulation, analytical comparability and patient preference considerations for large volume devicesIndrajit Ghosh, Daniel Miranda, Tanmay A Kulkarni, et al.
Pharmaceutics|March 26, 2022
Prodrug Therapies for Infectious and Neurodegenerative DiseasesMilica Markovic, Suyash Deodhar, Jatin Machhi, et al.
Advanced Drug Delivery Reviews|July 14, 2023
Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infectionMohammad Ullah Nayan, Brady Sillman, Mahmudul Hasan, et al.
Research Square|March 4, 2025
An Ultra-Long-Acting Dimeric Bictegravir Prodrug Defined by a Short Pharmacokinetic TailBenson Edagwa, Mohammad Ullah Nayan, Brady Sillman, et al.
Nature Communications|September 17, 2021
Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profilesDenise A Cobb, Nathan Smith, Suyash Deodhar, et al.
Nature Communications|January 21, 2026
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tailMohammad Ullah Nayan, Brady Sillman, Srijanee Das, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Therapeutic Delivery|November 17, 2018
Long circulating liposomes: challenges and opportunitiesSuyash Deodhar, Alekha K Dash
Biotech (Basel (Switzerland))|July 13, 2022
Non-Viral Vectors for Delivery of Nucleic Acid Therapies for CancerShrey Kanvinde, Tanmay Kulkarni, Suyash Deodhar, et al.
Biotech (Basel (Switzerland))|May 23, 2023
Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary FibrosisShrey Kanvinde, Suyash Deodhar, Tanmay A Kulkarni, et al.
Mabs|June 8, 2026
Subcutaneous drug delivery of high concentration antibody products - part 2: formulation, device options, and clinical bridging strategies for patient-centric commercial presentationsIndrajit Ghosh, Suyash Deodhar, Hiten Gutka, et al.
Journal of Pharmaceutical Sciences|July 24, 2025
Development roadmap for subcutaneous delivery of high dose biologics - high concentration formulation, analytical comparability and patient preference considerations for large volume devicesIndrajit Ghosh, Daniel Miranda, Tanmay A Kulkarni, et al.
Pharmaceutics|March 26, 2022
Prodrug Therapies for Infectious and Neurodegenerative DiseasesMilica Markovic, Suyash Deodhar, Jatin Machhi, et al.
Advanced Drug Delivery Reviews|July 14, 2023
Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infectionMohammad Ullah Nayan, Brady Sillman, Mahmudul Hasan, et al.
Research Square|March 4, 2025
An Ultra-Long-Acting Dimeric Bictegravir Prodrug Defined by a Short Pharmacokinetic TailBenson Edagwa, Mohammad Ullah Nayan, Brady Sillman, et al.
Nature Communications|September 17, 2021
Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profilesDenise A Cobb, Nathan Smith, Suyash Deodhar, et al.
Nature Communications|January 21, 2026
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tailMohammad Ullah Nayan, Brady Sillman, Srijanee Das, et al.
Pageof 2